Market Closed -
Nyse
04:00:02 2024-06-07 pm EDT
|
5-day change
|
1st Jan Change
|
56.41
USD
|
+2.47%
|
|
-4.94%
|
0.00%
|
Fiscal Period: December |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,743
|
-
|
-
|
Enterprise Value (EV)
1 |
16,904
|
16,350
|
15,547
|
P/E ratio
|
14.7
x
|
14.2
x
|
11.1
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.2
x
|
1.19
x
|
1.16
x
|
EV / Revenue
|
2.08
x
|
2
x
|
1.86
x
|
EV / EBITDA
|
7.94
x
|
7.73
x
|
7.4
x
|
EV / FCF
|
21.9
x
|
18.1
x
|
14.8
x
|
FCF Yield
|
4.56%
|
5.52%
|
6.74%
|
Price to Book
|
2.41
x
|
2.16
x
|
1.81
x
|
Nbr of stocks (in thousands)
|
172,710
|
-
|
-
|
Reference price
2 |
56.41
|
56.41
|
56.41
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
8,109
|
8,180
|
8,367
|
EBITDA
1 |
-
|
2,128
|
2,116
|
2,102
|
EBIT
1 |
-
|
1,758
|
1,627
|
1,674
|
Operating Margin
|
-
|
21.68%
|
19.88%
|
20.01%
|
Earnings before Tax (EBT)
1 |
1,667
|
917
|
1,008
|
1,105
|
Net income
1 |
1,346
|
905
|
919
|
878
|
Net margin
|
-
|
11.16%
|
11.23%
|
10.49%
|
EPS
2 |
-
|
3.825
|
3.980
|
5.090
|
Free Cash Flow
1 |
-
|
771.2
|
903.2
|
1,048
|
FCF margin
|
-
|
9.51%
|
11.04%
|
12.52%
|
FCF Conversion (EBITDA)
|
-
|
36.24%
|
42.68%
|
49.87%
|
FCF Conversion (Net income)
|
-
|
85.21%
|
98.28%
|
119.36%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
Announcement Date
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
2,016
|
2,055
|
2,020
|
2,002
|
2,005
|
EBITDA
1 |
520
|
528.2
|
549.5
|
480.8
|
544.5
|
EBIT
1 |
484
|
440.9
|
444.1
|
384
|
387.9
|
Operating Margin
|
24.01%
|
21.45%
|
21.98%
|
19.18%
|
19.35%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
231
|
287.6
|
203.4
|
234.8
|
Net margin
|
-
|
11.24%
|
14.24%
|
10.16%
|
11.71%
|
EPS
2 |
-
|
0.6300
|
0.9600
|
0.4700
|
0.8100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/9/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
7,162
|
6,607
|
5,804
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
3.366
x
|
3.122
x
|
2.762
x
|
Free Cash Flow
1 |
-
|
771
|
903
|
1,048
|
ROE (net income / shareholders' equity)
|
-
|
21.2%
|
23.3%
|
23%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
23.40
|
26.20
|
31.20
|
Cash Flow per Share
2 |
-
|
6.940
|
8.750
|
-
|
Capex
1 |
-
|
450
|
450
|
450
|
Capex / Sales
|
-
|
5.55%
|
5.5%
|
5.38%
|
Announcement Date
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
56.41
USD Average target price
65.75
USD Spread / Average Target +16.56% Consensus |
1st Jan change
|
Capi.
|
---|
| 0.00% | 9.74B | | +24.66% | 88.38B | | -21.76% | 77.56B | | +8.45% | 28.74B | | +7.94% | 18.45B | | -13.50% | 16.57B | | +77.51% | 13.65B | | +76.96% | 13.06B | | +4.72% | 12.61B | | +36.67% | 12.56B |
Other Healthcare Facilities & Services
|